Insights

Two multiple sclerosis experts discuss long-term and real-world data with oral therapies in the treatment of relapsing-remitting multiple sclerosis (RRMS) that was presented at ACTRIMS 2022.

Experts in sleep medicine provide key insights on a series of patient cases and evaluate the use of novel agents in the treatment landscape for narcolepsy.

Expert neurologists examine strategies for optimizing treatment formulations in the management of OFF episodes in Parkinson disease and highlight the importance of patient education.

Klaus Schmierer, MB BS, PhD, FRCP, discusses how patients with multiple sclerosis have been impacted by the COVID-19 pandemic, including guideline recommendations regarding vaccinations.

Two experts discuss what it means to have an off-episode as a patient with Parkinson’s disease, as well as how to live with them and what can be done to alleviate adverse events.

Alireza Atri, MD, PhD, discusses the many methods of testing and forming a diagnosis for patients with Alzheimer’s disease, highlighting the recent FDA approval of aducanumab and its impact.

Jeffrey L. Cummings, MD, ScD, discusses the Alzheimer’s disease and the advances recently made to improve the treatment landscape, specifically with aducanumab.

David Kudrow, MD, provides a discussion on the available treatment options for migraine management and prevention.

Elizabeth Thiele, MD, PhD, and Elaine C. Wirrell, MD, discuss the rare pediatric epilepsy conditions Dravet syndrome and Lennox-Gastaut syndrome, from prevalence to the approval of new therapies.

Expert neurologist and sleep specialist Chris Winter, MD, provides practical perspectives on the identification and management of narcolepsy and excessive daytime sleepiness.